The Kent Oncology Centre’s neuro-oncology service at Maidstone and Tunbridge Wells NHS Trust (MTW) has once again been recognised as a national leader in brain tumour care, earning the prestigious Tessa Jowell Centre of Excellence award for the second time running.

This achievement is part of the Tessa Jowell Brain Cancer Mission (TJBCM) and highlights the centre’s commitment to outstanding care, research, and patient experience.

The centre is part of the King’s Health Partners, a major healthcare partnership that includes King’s College Hospital, Guy’s Hospital, St Thomas’ Hospital, and our Kent Oncology Centre.

Together, the collaborative partnership aims to bring the best of research, clinical care and education to improve outcomes for patients.

To receive this award, the Kent Oncology Centre went through a detailed review led by experts, including NHS professionals, researchers and patients. The review looked at everything from the quality of treatment and care to patient feedback collected by the Brain Tumour Charity.

Being named a Centre of Excellence means that patients can feel confident they are receiving some of the best care available in the NHS. It also recognises the hard work and dedication of the staff who go above and beyond to support those affected by brain tumours.

Each year, over 12,000 adults in the UK are diagnosed with a brain tumour. These cancers are the leading cause of cancer-related deaths in people under 40. While a cure remains out of reach, initiatives like the Tessa Jowell Centre of Excellence programme aim to make sure every patient has access to the highest standard of care and support.